Bioinformatics analysis has revealed that dysregulated fat mass and obesity-associated protein (FTO) and METTL3 may contribute to the development and progression of ccRCC by influencing immune responses (Zhao and Lu, 2021). The gene discussed is FTO; the disease is nonpapillary renal cell carcinoma.